Clinical Trial Update: Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A terminated Phase 1/2 clinical trial evaluated Imatinib in combination with Dacarbazine and Capecitabine for medullary thyroid carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medullary Thyroid Carcinoma

Drugs mentioned

• Capecitabine (capecitabine)
• Dacarbazine (dacarbazine)
• Imatinib (imatinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Solid Tumor, Thyroid Cancer | Phase 1, Phase 2 | Status: TERMINATED